Acceleron Pharma
Earnings Date & Report
Last updated:
Acceleron Pharma’s last earnings date was on 4 Nov 2021. It reported its quarterly earnings per share (EPS) reaching -$1.14, beating the estimated value of -$1.15 by $0.01. The company’s quarterly earnings increased by 51.58% to 34.2M US dollars compared to the same quarter of the previous year. Over the last year, Acceleron Pharma’s earnings per share have dropped by 72.73%.
Acceleron Pharma stock Earnings report, Estimates & History
| 2017-03-01 | -0.55 | -0.51 |
|---|---|---|
| 2017-05-08 | -0.54 | -0.66 |
| 2017-08-03 | -0.62 | -0.77 |
| 2017-11-07 | -0.64 | -0.65 |
| 2018-02-27 | -0.61 | -0.62 |
| 2018-05-08 | -0.64 | -0.58 |
| 2018-08-02 | -0.64 | -0.63 |
| 2018-10-30 | -0.66 | -0.63 |
| 2019-02-27 | -0.68 | -0.75 |
| 2019-05-09 | -0.59 | -0.74 |
| 2019-08-05 | -0.3 | -0.34 |
| 2019-11-06 | -0.82 | -0.86 |
| 2020-02-27 | -0.29 | -0.44 |
| 2020-05-11 | -0.86 | -0.95 |
| 2020-08-06 | -0.57 | -0.34 |
| 2020-11-05 | -0.61 | -0.66 |
| 2021-02-25 | -0.59 | -0.95 |
| 2021-05-06 | -0.81 | -1.05 |
| 2021-08-05 | -0.92 | -1.05 |
| 2021-11-04 | -1.15 | -1.14 |
Estimated - a value of Apple’s earnings per share estimated by analysts based on its past and current financial statements.
Reported - a real value of Apple’s earnings per share reported by the company.
Acceleron Pharma stock earnings history by quarter
| Date | Estimated EPS | Reported EPS | Estimated revenue | Actual revenue | Earnings call | |
|---|---|---|---|---|---|---|
| 4 Nov 2021 | Beat | -$1.15 | -$1.14 | 34.56M | 34.19M | |
| 5 Aug 2021 | Missed | -$0.92 | -$1.05 | 30.8M | 27.94M | |
| 6 May 2021 | Missed | -$0.81 | -$1.05 | 28.95M | 24.75M | |
| 25 Feb 2021 | Missed | -$0.59 | -$0.95 | 31.39M | 25.86M | Earnings Call Transcript |
| 5 Nov 2020 | Missed | -$0.61 | -$0.66 | 20.85M | 22.56M | |
| 6 Aug 2020 | Beat | -$0.57 | -$0.34 | 66.64M | 39.75M | |
| 11 May 2020 | Missed | -$0.86 | -$0.95 | 3.93M | 4.34M | Earnings Call Transcript |
| 27 Feb 2020 | Missed | -$0.29 | -$0.44 | 25.92M | 39.33M | Earnings Call Transcript |
| 6 Nov 2019 | Missed | -$0.82 | -$0.86 | 4.01M | 4.20M | Earnings Call Transcript |
| 5 Aug 2019 | Missed | -$0.3 | -$0.34 | 24.41M | 27.66M | Earnings Call Transcript |
| 9 May 2019 | Missed | -$0.59 | -$0.74 | 2.21M | 2.78M | Earnings Call Transcript |
| 27 Feb 2019 | Missed | -$0.68 | -$0.75 | 3.45M | 3.81M | Earnings Call Transcript |
| 30 Oct 2018 | Beat | -$0.66 | -$0.63 | 3.41M | 3.25M | Earnings Call Transcript |
| 2 Aug 2018 | Beat | -$0.64 | -$0.63 | 3.74M | 3.68M | Earnings Call Transcript |
| 8 May 2018 | Beat | -$0.64 | -$0.58 | 3.56M | 3.23M | |
| 27 Feb 2018 | Missed | -$0.61 | -$0.62 | 3.64M | 3.70M | Earnings Call Transcript |
| 7 Nov 2017 | Missed | -$0.64 | -$0.65 | 2.96M | 3.01M | Earnings Call Transcript |
| 3 Aug 2017 | Missed | -$0.62 | -$0.77 | 2.46M | 3.05M | Earnings Call Transcript |
| 8 May 2017 | Missed | -$0.54 | -$0.66 | 3.03M | 3.70M | Earnings Call Transcript |
| 1 Mar 2017 | Beat | -$0.55 | -$0.51 | 3.63M | 3.36M | Earnings Call Transcript |
Acceleron Pharma Earnings report FAQs
When is Acceleron Pharma's next Earnings date?
The company has not set the next earnings date yet. The latest Acceleron Pharma's earnings date was on 5 Nov 2020.
What are earnings?
Earnings are the net income of a company after all taxes and expenses have been deducted. They are the main figure for determining the price of a company's shares.
What does EPS stand for?
EPS stands for earnings per share, which is the basic measure of a company's earnings. It indicates how much money each share earned for the company.
How to calculate earnings per share?
Earnings per share (EPS) can be calculated by dividing a company's net income by the number of common shares outstanding. If the company pays preferred dividends, they are first subtracted from the company’s net income.
Formula:
What is earnings per share estimate?
Earnings estimate is analysts’ prediction of a company’s earnings value in the next quarter or fiscal year based on past and current financial statements of a company. It is an important indicator for both current and future investors.